Context Therapeutics (CNTX) Stock Chart & Stock Price History → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free CNTX Stock Alerts $1.30 -0.11 (-7.80%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Context Therapeutics Stock Price Performance5 Day Performance-1.52%1 Month Performance+1.56%3 Month Performance+41.26%6 Month Performance+22.64%Year-To-Date Performance+15.04%1 Year Performance+125.42% Receive CNTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW CNTX Stock Chart for Thursday, April, 25, 2024 CNTX Chart by TradingView Context Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$1.41$1.30-7.80%$1.44$1.3036,608 shs$0.0004/23/2024$1.36$1.41+3.68%$1.48$1.3823,977 shs$0.0004/22/2024$1.32$1.36+3.03%$1.39$1.3013,903 shs$0.0004/19/2024$1.37$1.32-3.65%$1.45$1.325,702 shs$0.0004/18/2024$1.39$1.37-1.44%$1.50$1.3745,929 shs$0.0004/17/2024$1.46$1.39-4.79%$1.52$1.3733,798 shs$0.00 Get the Latest News and Ratings for CNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$1.51$1.46-3.31%$1.58$1.4336,225 shs$0.0004/15/2024$1.49$1.51+1.34%$1.58$1.4534,979 shs$0.0004/12/2024$1.52$1.49-1.97%$1.58$1.42115,081 shs$0.0004/11/2024$1.35$1.52+12.59%$1.60$1.34179,371 shs$0.0004/10/2024$1.31$1.35+3.05%$1.38$1.3042,542 shs$0.0004/09/2024$1.30$1.31+0.77%$1.34$1.2726,465 shs$0.0004/08/2024$1.27$1.30+2.36%$1.47$1.2835,358 shs$20.76 million04/05/2024$1.28$1.27-0.78%$1.36$1.269,865 shs$0.0004/04/2024$1.24$1.28+3.23%$1.30$1.2312,899 shs$20.44 million04/03/2024$1.36$1.24-8.82%$1.40$1.2460,604 shs$0.0004/02/2024$1.37$1.36-0.73%$1.40$1.3061,235 shs$22.03 million04/01/2024$1.38$1.37-0.72%$1.57$1.31488,239 shs$22.03 million03/29/2024$1.38$1.38$1.49$1.3856,044 shs$22.04 million03/28/2024$1.38$1.38$1.49$1.3856,044 shs$20.28 million03/27/2024$1.24$1.38+11.29%$1.47$1.25217,320 shs$20.12 million03/26/2024$1.28$1.24-3.13%$1.30$1.2064,685 shs$18.60 million03/25/2024$1.17$1.28+9.87%$1.30$1.18236,435 shs$18.60 million03/22/2024$1.07$1.17+8.88%$1.18$1.08118,794 shs$18.36 million03/21/2024$1.15$1.07-6.96%$1.24$1.06104,569 shs$17.56 million03/20/2024$1.10$1.15+4.55%$1.18$1.0853,284 shs$17.24 million03/19/2024$1.08$1.10+1.85%$1.16$1.0956,609 shs$17.57 million03/18/2024$1.09$1.08-0.92%$1.14$1.0721,243 shs$17.72 million03/15/2024$1.11$1.09-1.80%$1.12$1.0641,704 shs$18.36 million03/14/2024$1.15$1.11-3.48%$1.17$1.0610,252 shs$17.73 million03/13/2024$1.17$1.15-1.71%$1.18$1.1520,460 shs$19 million03/12/2024$1.19$1.17-1.68%$1.22$1.166,849 shs$19.16 million03/11/2024$1.20$1.19-0.83%$1.24$1.176,138 shs$19.16 million03/08/2024$1.15$1.20+4.35%$1.26$1.13226,094 shs$16.76 million03/07/2024$1.05$1.15+9.52%$1.18$1.1046,887 shs$18.68 million03/06/2024$1.17$1.05-10.26%$1.22$1.03104,240 shs$18.20 million03/05/2024$1.14$1.17+2.63%$1.19$1.0780,374 shs$18.69 million03/04/2024$1.15$1.14-0.87%$1.18$1.0944,920 shs$18.36 million03/01/2024$1.14$1.15+0.88%$1.18$1.1211,261 shs$18.37 million02/29/2024$1.19$1.14-4.20%$1.21$1.1023,263 shs$18.21 millionUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW02/28/2024$1.19$1.19$1.19$1.1133,101 shs$19.00 million02/27/2024$1.13$1.19+5.30%$1.20$1.1144,077 shs$19.00 million02/26/2024$1.16$1.13-2.58%$1.18$1.107,982 shs$18.05 million02/23/2024$1.16$1.16$1.17$1.098,061 shs$18.53 million02/22/2024$1.20$1.16-3.33%$1.28$1.16115,013 shs$18.53 million02/21/2024$1.15$1.20+4.71%$1.20$1.0853,450 shs$19.16 million02/20/2024$1.04$1.15+10.20%$1.17$1.10149,408 shs$18.30 million02/19/2024$1.04$1.04$1.08$1.0214,500 shs$16.61 million02/16/2024$1.02$1.04+1.95%$1.08$1.0214,575 shs$16.61 million02/15/2024$1.06$1.02-3.77%$1.14$0.9927,440 shs$16.29 million02/14/2024$1.13$1.06-6.19%$1.12$1.0630,727 shs$16.93 million02/13/2024$1.14$1.13-0.88%$1.17$1.054,562 shs$18.05 million02/12/2024$1.05$1.14+8.57%$1.16$1.0034,543 shs$18.21 million02/09/2024$0.99$1.05+6.06%$1.05$0.9917,051 shs$16.77 million02/08/2024$1.02$0.99-2.94%$1.03$0.997,962 shs$15.81 million02/07/2024$1.03$1.02-0.97%$1.05$0.995,989 shs$16.29 million02/06/2024$1.03$1.03$1.03$0.997,159 shs$16.45 million02/05/2024$1.03$1.03$1.03$0.985,339 shs$16.45 million02/02/2024$1.03$1.03$1.03$0.968,184 shs$16.45 million02/01/2024$1.02$1.03+0.98%$1.04$0.9713,631 shs$16.45 million01/31/2024$1.06$1.02-3.77%$1.06$1.0014,882 shs$16.29 million01/30/2024$1.03$1.06+2.91%$1.06$0.9610,744 shs$16.93 million01/29/2024$0.97$1.03+6.17%$1.04$0.9231,404 shs$16.45 million01/26/2024$0.92$0.97+5.41%$0.98$0.929,504 shs$15.49 million01/25/2024$0.95$0.92-3.13%$0.98$0.8969,016 shs$14.70 million01/24/2024$1.02$0.95-6.86%$1.05$0.9536,097 shs$15.17 million Related Companies: GRFS Stock Price Chart LVTX Stock Price Chart MYNZ Stock Price Chart NLSP Stock Price Chart PHVS Stock Price Chart PROC Stock Price Chart QLI Stock Price Chart TLSA Stock Price Chart ATNFW Stock Price Chart SXTPW Stock Price Chart Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.